| |
| Genus,
Inc. |
| Condensed
Consolidated Statements of Operations (Unaudited) |
| (Amounts
in thousands, except per share data) |
| |
|
| |
Three Months
Ended
|
|
Nine Months
Ended
|
| |
September
30,
|
|
September
30,
|
| |
2001
|
|
2000
|
|
2001
|
|
2000
|
| |
| Net
sales |
$
15,094 |
|
$
14,543 |
|
$
43,062 |
|
$24,955
|
|
| Costs
and expenses: |
| Cost
of goods sold |
10,300
|
|
8,044 |
|
27,523 |
|
15,063 |
| Research
and development |
2,592 |
|
2,034 |
|
8,838 |
|
5,762 |
| Selling,
general and administrative |
2,739 |
|
2,820 |
|
7,971 |
|
8,043 |
| Income
(loss) from operations |
(537) |
|
1,645 |
|
(1,270) |
|
(3,913) |
|
| Other,
net |
(207) |
|
101 |
|
(127) |
|
383 |
| Income
(loss) before income taxes |
(744) |
|
1,746 |
|
(1,397) |
|
(3,530) |
|
| Provisions
for Income taxes |
- |
|
100 |
|
69 |
|
450 |
|
| Net
income (loss) before cumulative effect of change in accounting
principle |
(744) |
|
1,646 |
|
(1,466) |
|
(3,980) |
|
| Cumulative
effect of change in accounting principle |
|
|
|
|
|
|
(6,770) |
|
| Net
income (loss) |
$(744) |
|
$1,646 |
|
$(1,466) |
|
$
(10,750) |
|
| Net
income (loss) per common share and per common share assuming
basic shares |
$(0.03) |
|
$0.09 |
|
$(0.07) |
|
$(0.57) |
| Net
income (loss) per common share and per common share assuming
dilution |
$(0.03) |
|
$0.08 |
|
$(0.07) |
|
$(0.57) |
| Share
used in per share calculations - basic |
22,268 |
|
19,126 |
|
20,793 |
|
18,845 |
| Shares
used in per share calculations - diluted |
22,268 |
|
20,593 |
|
20,793 |
|
18,845 |
| |
| Condensed
Consolidated Balance Sheets (Unaudited) |
| (Amounts
in thousands) |
| |
| |
September
30, 2001
|
|
December
31, 2000
|
| Assets: |
| Cash
and cash equivalents |
$
5,514 |
|
$
3,136 |
| Accounts
receivable, net |
5,041 |
|
8,479 |
| Inventories |
11,956 |
|
21,849 |
| Other
current assets |
763 |
|
675 |
| Total
current assets |
23,274 |
|
34,139 |
|
| Property
and equipment, net |
15,940 |
|
10,207 |
| Other
assets, net |
250 |
|
189 |
| Total
assets |
$39,464 |
|
$44,535 |
|
| Liabilities,
redeemable preferred stock, and shareholder's equity: |
| Deferred
revenue |
$4,390 |
|
$18,562 |
| Other
current liabilities |
17,737 |
|
14,681 |
| Shareholders'
equity |
17,337 |
|
11,292 |
| Total
liabilities, redeemable preferred stock, and shareholders' equity |
$39,464 |
|
$44,535 |
|
|
